共 50 条
Tumor-infiltrating lymphocytes A new hope
被引:7
|作者:
Sarnaik, Amod A.
[1
,2
]
Hwu, Patrick
[1
,2
]
Mule, James J.
[1
,2
]
Pilon-Thomas, Shari
[1
,3
]
机构:
[1] H Lee Moffitt Canc Ctr & Res Inst, Immunol Program, Tampa, FL 33612 USA
[2] H Lee Moffitt Canc Ctr & Res Inst, Cutaneous Oncol Program, Tampa, FL 33612 USA
[3] H Lee Moffitt Canc Ctr & Res Inst, Ctr Immunizat & Infect Res Canc, Tampa, FL USA
来源:
关键词:
T-CELLS;
IMMUNOTHERAPY;
CANCER;
D O I:
10.1016/j.ccell.2024.06.015
中图分类号:
R73 [肿瘤学];
学科分类号:
100214 ;
摘要:
Tumor-infiltrating lymphocytes (TILs) can be massively expanded from resected tumors and used as a cellular treatment for advanced malignancies. TILs require a preparative non-myeloablative chemotherapy followed by an abbreviated course of interleukin-2. Here, we review the historical development of TIL therapy and discuss potential solutions to ongoing roadblocks that may result in broader and improved efficacy for patients afflicted with treatment-refractory, advanced cancer.
引用
收藏
页数:4
相关论文